Stay updated on BI 695501 vs Adalimumab in Active RA Clinical Trial
Sign up to get notified when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.

Latest updates to the BI 695501 vs Adalimumab in Active RA Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no substantive changes to the study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page shows an updated site revision to v3.4.2, and the prior funding-status notice (v3.4.1) has been removed.SummaryDifference0.2%

- Check41 days agoChange DetectedA government funding notice about potential delays and NIH operations has been added to the page, and the revision shows v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded a glossary toggle (Show glossary). Updated QC-related labels for capitalization and introduced a new site version tag 'Revision: v3.4.0'.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision v3.3.4 was added and revision v3.3.3 was removed. This is a minor housekeeping update to the page's revision history.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a comprehensive Locations section listing trial sites by state (e.g., AL, AZ, CA, CO, FL, etc.). Updated revision to v3.3.3 and removed v3.3.2/HHS Vulnerability Disclosure.SummaryDifference1%

Stay in the know with updates to BI 695501 vs Adalimumab in Active RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.